Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality
Authors:
- 14 January 2015
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 13 (3) , 390-397
Abstract
No abstract availableKeywords
Funding Information
- Vienna Cancer and Thrombosis Study
- Austrian National Bank's Anniversary Fund (14744)
- Austrian Science Fund (FWF-SFB-54)
- Medical University of Vienna
This publication has 13 references indexed in Scilit:
- Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and MeierJournal of Thrombosis and Haemostasis, 2012
- Accounting for death as a competing risk in cancer-associated thrombosis studiesThrombosis Research, 2012
- Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for CancerNew England Journal of Medicine, 2012
- Cancer and coagulationAmerican Journal of Hematology, 2012
- Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolismContemporary Clinical Trials, 2011
- Prediction of venous thromboembolism in cancer patientsBlood, 2010
- D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis StudyJournal of Clinical Oncology, 2009
- Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with CancerNew England Journal of Medicine, 2003
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Estimation of failure probabilities in the presence of competing risks: new representations of old estimatorsStatistics in Medicine, 1999